Feil Family Brain & Mind Research Institute

Publications

Found 830 results

] Title Type Year

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

K

Kim E, Woo M-S, Qin L, Ma T, Beltran CD, Bao Y, Bailey JA, Corbett D, Ratan RR, Lahiri DK et al.. 2015. Daidzein Augments Cholesterol Homeostasis via ApoE to Promote Functional Recovery in Chronic Stroke.. J Neurosci. 35(45):15113-26.

Kim E, Yang J, Park KWoo, Cho S. 2017. Inhibition of VEGF Signaling Reduces Diabetes-Exacerbated Brain Swelling, but Not Infarct Size, in Large Cerebral Infarction in Mice.. Transl Stroke Res.

Kim E, Cho S. 2016. Microglia and Monocyte-Derived Macrophages in Stroke.. Neurotherapeutics. 13(4):702-718.

Kloske CM, Belloy ME, Blue EE, Bowman GR, Carrillo MC, Chen X, Chiba-Falek O, Davis AA, Di Paolo G, Garretti F et al.. 2024. Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference.. Alzheimers Dement.

Knepp B, Navi BB, Rodriguez F, DeAngelis LM, Elkind MSV, Iadecola C, Sherman CP, Tagawa ST, Saxena A, Ocean AJ et al.. 2024. Ischemic Stroke with Comorbid Cancer Has Specific miRNA-mRNA Networks in Blood That Vary by Ischemic Stroke Mechanism.. Ann Neurol. 96(3):565-581.

Kobayashi M, Benakis C, Anderson C, Moore MJ, Poon C, Uekawa K, Dyke JP, Fak JJ, Mele A, Park CY et al.. 2019. AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic Stroke.. Cell Rep. 28(4):979-991.e6.

Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS. 2018. Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.

Kodama L, Guzman E, Etchegaray JI, Li Y, Sayed FA, Zhou L, Zhou Y, Zhan L, Le D, Udeochu JC et al.. 2019. Microglial microRNAs mediate sex-specific responses to tau pathology.. Nat Neurosci.

Koizumi K, Hattori Y, Ahn SJi, Buendia I, Ciacciarelli A, Uekawa K, Wang G, Hiller A, Zhao L, Voss HU et al.. 2018. Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function.. Nat Commun. 9(1):3816.

Koizumi K, Wang G, Park L. 2016. Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations.. Cell Mol Neurobiol. 36(2):155-65.

Kong W, Frouard J, Xie G, Corley MJ, Helmy E, Zhang G, Schwarzer R, Montano M, Sohn P, Roan NR et al.. 2024. Neuroinflammation generated by HIV-infected microglia promotes dysfunction and death of neurons in human brain organoids.. PNAS Nexus. 3(5):pgae179.

Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM et al.. 2017. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.. Mol Neurodegener. 12(1):76.

Kozlenkov A, Vadukapuram R, Zhou P, Fam P, Wegner M, Dracheva S. 2024. Novel method of isolating nuclei of human oligodendrocyte precursor cells reveals substantial developmental changes in gene expression and H3K27ac histone modification.. Glia. 72(1):69-89.

Krusche P, Trigg L, Boutros PC, Mason CE, De La Vega FM, Moore BL, Gonzalez-Porta M, Eberle MA, Tezak Z, Lababidi S et al.. 2019. Best practices for benchmarking germline small-variant calls in human genomes.. Nat Biotechnol.

Krusche P, Trigg L, Boutros PC, Mason CE, De La Vega FM, Moore BL, Gonzalez-Porta M, Eberle MA, Tezak Z, Lababidi S et al.. 2019. Author Correction: Best practices for benchmarking germline small-variant calls in human genomes.. Nat Biotechnol.

Kuceyeski A, Monohan E, Morris E, Fujimoto K, Vargas W, Gauthier SA. 2018. Baseline biomarkers of connectome disruption and atrophy predict future processing speed in early multiple sclerosis.. Neuroimage Clin. 19:417-424.

Kuceyeski A, Navi BB, Kamel H, Raj A, Relkin N, Toglia J, Iadecola C, O'Dell M. 2016. Structural connectome disruption at baseline predicts 6-months post-stroke outcome.. Hum Brain Mapp. 37(7):2587-601.

Kudo R, Safonov A, Jones C, Moiso E, Dry JR, Shao H, Nag S, da Silva EM, Yildirim SYeni, Li Q et al.. 2024. Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion.. Cancer Cell. 42(11):1919-1935.e9.

Kumar A, Karuppagounder SS, Chen Y, Corona C, Kawaguchi R, Cheng Y, Balkaya M, Sagdullaev BT, Wen Z, Stuart C et al.. 2023. 2-Deoxyglucose drives plasticity via an adaptive ER stress-ATF4 pathway and elicits stroke recovery and Alzheimer's resilience.. Neuron. 111(18):2831-2846.e10.

Kummer BR, Gialdini G, Sevush JL, Kamel H, Patsalides A, Navi BB. 2016. External Validation of the Cincinnati Prehospital Stroke Severity Scale.. J Stroke Cerebrovasc Dis. 25(5):1270-1274.

Kummer BR, Bhave PD, Merkler AE, Gialdini G, Okin PM, Kamel H. 2015. Demographic Differences in Catheter Ablation After Hospital Presentation With Symptomatic Atrial Fibrillation.. J Am Heart Assoc. 4(9):e002097.

Kummer BR, Díaz I, Wu X, Aaroe AE, Chen ML, Iadecola C, Kamel H, Navi BB. 2019. Associations between cerebrovascular risk factors and parkinson disease.. Ann Neurol. 86(4):572-581.

Kummer BR, Lerario MP, Navi BB, Ganzman AC, Ribaudo D, Mir SA, Pishanidar S, Lekic T, Williams O, Kamel H et al.. 2018. Clinical Information Systems Integration in New York City's First Mobile Stroke Unit.. Appl Clin Inform. 9(1):89-98.

Kuo S-H, Tasset I, Cheng MM, Diaz A, Pan M-K, Lieberman OJ, Hutten SJ, Alcalay RN, Kim S, Ximénez-Embún P et al.. 2022. Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy.. Sci Adv. 8(6):eabm6393.

Kuszak AJ, Espey MGraham, Falk MJ, Holmbeck MA, Manfredi G, Shadel GS, Vernon HJ, Zolkipli-Cunningham Z. 2017. Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.. Annu Rev Pathol.